A roadside-style saliva test may look simple, but workplace drug testing is not simply a matter of collecting a sample and reading a result. AS/NZS 4760 oral fluid testing provides the procedural framework for collecting and analysing oral fluid specimens in a way that supports reliable, respectful and defensible workplace processes.
For employers in mining, construction, transport, agriculture and industrial work, the standard matters because testing decisions can affect site access, safety controls and workforce confidence. A sound program needs more than a device. It needs a clear policy, trained collectors, privacy controls, documented steps and an appropriate process for results that require further review.
What AS/NZS 4760 oral fluid testing covers
AS/NZS 4760 is the Australian and New Zealand standard for procedures for specimen collection and the detection and quantitation of drugs in oral fluid. In workplace terms, it provides a benchmark for how oral fluid testing should be managed, from specimen collection through to screening and, where required, laboratory confirmation.
The standard helps reduce avoidable variation in the testing process. It addresses practical controls such as identifying the donor, using suitable collection equipment, maintaining specimen integrity, recording relevant details and managing chain of custody. These controls matter when a result may lead to a worker being removed from a safety-sensitive task or when an employer needs to demonstrate that its procedure was fair and consistently applied.
AS/NZS 4760 does not replace a workplace alcohol and other drugs policy. Nor does it tell a business when to test or what employment action to take. Those decisions should be set out in the organisation’s own policy and managed in line with its obligations, contracts and site requirements. The standard supports the quality of the testing process itself.
Why oral fluid testing is used at work
Oral fluid testing is commonly selected for workplace programs because collection is observable and can usually be completed on site. This reduces some of the specimen substitution and tampering risks associated with other testing methods, while allowing a relatively prompt initial screening outcome.
It can be a practical option for pre-access testing, post-incident processes, reasonable-cause testing and random programs, where these are supported by a clear workplace policy. For remote and regional operations, the ability to conduct collection at the workplace can also make testing more manageable without unnecessary disruption to crews and supervisors.
However, oral fluid testing is not a direct measure of impairment. A test result identifies whether a substance or its markers have been detected at or above an applicable cut-off under the relevant process. Fitness for a particular role, the circumstances of an incident and next steps under a workplace policy are separate matters. Employers should avoid treating a screening device as the sole answer to every safety or people-management question.
Screening results and confirmation are different steps
One of the most important distinctions in an AS/NZS 4760 process is the difference between an initial screening result and a confirmed laboratory result.
An on-site device may provide a negative result or indicate a non-negative result. A non-negative screening result is not the same as a confirmed result. It means the sample requires the next step specified by the testing procedure and workplace policy. Depending on the program, that may involve collecting a further specimen, applying chain-of-custody controls and sending the sample for laboratory analysis.
This distinction protects both the workplace and the worker. It helps employers make measured, policy-based decisions rather than jumping to conclusions from an initial screen. It also gives workers confidence that a result with potential consequences is handled through a defined process rather than informal judgement.
The practical details matter. Collection timing, specimen volume, device instructions, expiry dates, storage conditions, documentation and custody records can all affect the integrity of the process. A rushed collection or incomplete paperwork can create uncertainty later, particularly after a serious incident or a disputed result.
Building a workplace process that workers can trust
Testing is most effective when it sits inside a broader alcohol and other drugs framework. Workers should know the purpose of the program, when testing may occur, how samples are collected, what happens after a non-negative screen and how personal information is handled. Surprises and vague rules create resistance. Clear expectations support safer decisions before anyone is asked to provide a sample.
A practical policy should state the types of testing the business may use and identify who is authorised to arrange or conduct it. It should also cover notification, consent requirements, privacy, result management, escalation pathways and record retention. The wording should match the site, workforce agreements and operational risks rather than relying on a generic document copied from another industry.
For example, a civil construction business with mobile crews may need a process that works at changing sites and outside standard office hours. A mine or major project may need to align its arrangements with principal contractor or site-entry requirements. A transport operator may need practical steps for managing a driver who cannot continue a safety-sensitive duty while a non-negative result is being addressed under the company process.
Consistency is essential. Similar circumstances should be managed in the same way, regardless of whether the worker is a long-term employee, contractor, supervisor or visitor. That includes maintaining dignity during collection and limiting result information to people with a genuine need to know.
Collection controls that support defensible results
The collection stage is where good intentions become a repeatable safety process. Collectors need to follow the relevant device instructions and the workplace procedure each time, not just when conditions are easy.
Key collection controls generally include confirming the donor’s identity, explaining the process, checking that the collection area is suitable, observing any pre-collection requirements set by the method, and documenting the collection accurately. The collector should also ensure the device is within date, stored as required and used according to its instructions.
If a sample needs to be sent for confirmation, chain of custody becomes particularly important. The record should show who collected the specimen, how it was identified, when it changed hands and how it was prepared for transport. Gaps in this record can undermine confidence in the result, even when the original collection was properly performed.
Privacy should be designed into the process. Testing should be conducted discreetly where practical, records should be securely managed, and unnecessary discussion of results should be avoided. In close-knit regional workplaces, this is especially important. Confidentiality supports fairness, worker trust and the willingness to raise safety concerns early.
Common mistakes to avoid
The most frequent problems are procedural rather than technical. Using an oral fluid device without a documented testing policy, treating a non-negative screen as final, failing to train collectors and keeping incomplete records can all create avoidable risk.
Another common mistake is assuming that one approach suits every testing circumstance. Post-incident testing, random testing and site-access testing may each require different arrangements for notification, supervision, transport, work allocation and escalation. The safest approach is to define those pathways before an event occurs, then brief the people who will need to apply them.
Businesses should also review their program regularly. Changes to project requirements, workforce structure, collection devices, site rules or company procedures can affect how testing is delivered. A periodic review helps ensure the process remains practical for the work being performed and aligned with current operational requirements.
Choosing support for workplace testing
A testing provider should understand the difference between supplying a test and supporting a workplace process. Ask how collection procedures are managed, whether collectors understand privacy and chain-of-custody requirements, and how non-negative screening results are handled under the agreed program.
For Queensland workplaces, local experience can make a real difference when testing needs to happen around shift changes, remote work fronts or site mobilisation. Corrsafe provides practical workplace drug and alcohol testing support for businesses that need a clear, professional process built around their operational environment.
The aim is not to make testing punitive or performative. It is to create a consistent safety control that workers understand, supervisors can apply and employers can rely on when the pressure is on. When the procedure is planned, respectful and properly documented, every move is more likely to be a safe one.